全球医药产业研究与发展的最新趋势.pptxVIP

全球医药产业研究与发展的最新趋势 胡江滨 美中药协 (SAPA) 北京, 2004 ;报告内容;;;;;;Termination reasons were provided for 498 of the 538 NASs for which development was terminated between 1999 and 2001.;目前新药开发遇到的困境;面对上述的挑战，国际制药界采取了些什么对策？;New Trends in Drug Development目前的新走向;Many blockbuster drugs are externally sourced许多重磅炸弹都是从其它公司引进的。;Revenues from in-licensing are increasing…引进项目的产品销售正在不断提高;Why License in/ Partnering;项目引进包括哪些方面;项??引进案例 1999-2002 ;Competitors for a given licensing deal;Cross Functional Deal Team;Due Diligence;Large Number of Opportunities Evaluated for Every Deal Closed;New Trends in Drug Development目前的新走向;Augmentin Claritin Zestril;Life Cycle Management ;Global Drug Delivery Market, 2001;;Success Story of LCM;Wellbutrin: Growth of a Blockbuster;Why Develop Fixed Combination Products?;New Trends in Drug Development目前的新走向;Outsourcing;新药研发的费用分布 2001;;;;Conclusions 结语;Questions??? ???